Pharmaceutical manufacturing

From l-r., Richard A. Gonzalez , Chairman and Chief Executive Officer AbbVie Inc., Pascal Soriot, Executive Director and Chief Executive Officer AstraZeneca, Giovanni Caforio, M.D. Chairman of the Board and Chief Executive Officer Bristol-Myers Squibb Co., Jennifer Taubert, Executive Vice President, Worldwide Chairman, Janssen Pharmaceuticals Johnson & Johnson, Kenneth C. Frazier, Chairman and Chief Executive Officer Merck & Co., Inc., Albert Bourla, DVM, Ph.D. Chief Executive Office Pfizer, Olivier Brandicourt, M.D. Chief Executive Officer Sanofi, wait to testify before the Senate Finance Committee hearing on drug prices, Tuesday, Feb. 26, 2019 on Capitol Hill in Washington. (AP Photo/Pablo Martinez Monsivais)
February 26, 2019 - 1:41 pm
WASHINGTON (AP) — The Latest on top pharmaceutical executives testifying before Senate lawmakers on rising drug prices (all times local): 1:30 Senators are urging top pharmaceutical executives to help Congress take action against the industry's worst actors who hike prices on once-cheap drugs...
Read More
February 24, 2019 - 4:43 pm
WASHINGTON (AP) — With health care a top issue for American voters, Congress may actually be moving toward doing something this year to address the high cost of prescription drugs. President Donald Trump, Democrats trying to retire him in 2020, and congressional incumbents of both parties all say...
Read More
FILE- In this Aug. 7, 2018, file photo a CVS Pharmacy building sign rests on a Jackson, Miss., store. CVS Health topped fourth-quarter earnings forecasts, but the nation’s second-largest drugstore chain also debuted a 2019 outlook that fell far short of Wall Street expectations. The company said Wednesday, Feb. 20, 2019, that it expects adjusted earnings to range between $6.68 and $6.88 this year. FactSet says analysts expect earnings of $7.35 per share. (AP Photo/Rogelio V. Solis, File)
February 20, 2019 - 9:15 am
CVS Health beat fourth-quarter earnings forecasts, but a struggling long-term care business took another huge bite out of the company's performance and its initial 2019 forecast was weaker than expected. Shares tumbled nearly 9 percent before the opening bell Wednesday. CEO Larry Merlo said in a...
Read More
FILE- In this Oct. 26, 2018, file photo Health and Human Services Secretary Alex Azar speaks about proposed reforms to Medicare Part B drug pricing policies at the Brookings Institute in Washington. The Trump administration says it is moving ahead with a plan to let patients directly receive prescription drug discounts negotiated behind-the-scenes between drugmakers, middlemen, and insurers. Azar said Thursday, Jan. 31, 2019, the proposed regulation would encourage the major industry players to channel any such discounts to consumers when they purchase their prescriptions. (AP Photo/Alex Brandon, File)
February 01, 2019 - 1:16 pm
WASHINGTON (AP) — The Trump administration's top health official asked Congress on Friday to pass its new prescription drug discount plan and provide it to all patients, not just those covered by government programs like Medicare. The plan would take now-hidden rebates among industry players like...
Read More
FILE - This May 1, 2018 file photo shows Merck corporate headquarters in Kenilworth, N.J. Merck & Co. reports earnings Friday, Feb. 1, 2019. (AP Photo/Seth Wenig, File)
February 01, 2019 - 8:58 am
Higher medicine sales and lower restructuring and other costs lifted drugmaker Merck to a $1.83 billion profit in the fourth quarter, as it edged past Wall Street expectations. The maker of blockbuster cancer drug Keytruda and Januvia diabetes pills lost $1.05 billion a year earlier, when it had a...
Read More
FILE- In this Oct. 26, 2018, file photo Health and Human Services Secretary Alex Azar speaks about proposed reforms to Medicare Part B drug pricing policies at the Brookings Institute in Washington. The Trump administration says it is moving ahead with a plan to let patients directly receive prescription drug discounts negotiated behind-the-scenes between drugmakers, middlemen, and insurers. Azar said Thursday, Jan. 31, 2019, the proposed regulation would encourage the major industry players to channel any such discounts to consumers when they purchase their prescriptions. (AP Photo/Alex Brandon, File)
January 31, 2019 - 7:55 pm
WASHINGTON (AP) — The Trump administration Thursday unveiled a plan to channel now-hidden prescription drug rebates directly to patients, saying it would bypass middlemen and lower prices for consumers. The proposed regulation from Health and Human Services Secretary Alex Azar would eliminate...
Read More
Trader Michael Unkonis, center, works on the floor of the New York Stock Exchange, Tuesday, Jan. 29, 2019. Stocks are opening slightly higher on Wall Street as several big U.S. companies reported solid results for the latest quarter. (AP Photo/Richard Drew)
January 29, 2019 - 3:44 pm
NEW YORK (AP) — Major U.S. stock indexes were mostly lower late Tuesday afternoon, placing the market on course for its second decline in a row. Losses in technology and media companies outweighed gains in industrial and health care stocks. Early gains faded as investors assessed a mixed bag of...
Read More
Sen. Chuck Grassley, R-Iowa, center, chairman of the Senate Finance Committee, is joined at left by Sen. Ron Wyden, D-Ore., the ranking member, at a hearing on the high price of prescription drugs, on Capitol Hill in Washington, Tuesday, Jan. 29, 2019. (AP Photo/J. Scott Applewhite)
January 29, 2019 - 12:14 pm
WASHINGTON (AP) — A senior Republican lawmaker said Tuesday he plans to investigate price spikes in the cost of insulin for people with diabetes as Congress opened hearings on the high cost of prescription drugs. "I have heard stories about people reducing their life-saving medicines, like insulin...
Read More
FILE- This Dec. 4, 2017, file photo shows a tablet of Pfizer's Viagra, left, and the company's generic version, sildenafil citrate, at Pfizer Inc., headquarters in New York. Pfizer Inc. reports earnings Tuesday, Jan. 29, 2019. (AP Photo/Richard Drew, File)
January 29, 2019 - 7:09 am
NEW YORK (AP) — Pfizer's strong profit for the fourth quarter is being overshadowed by a tepid outlook for the year. The drugmaker on Tuesday had a loss of $394 million, or 7 cents per share. Adjusted for non-recurring costs and costs related to mergers and acquisitions, however, per-share earnings...
Read More
FILE- In this Jan. 18, 2019, file photo specialist Michael Pistillo works on the floor of the New York Stock Exchange. The U.S. stock market opens at 9:30 a.m. EST on Friday, Jan. 25. (AP Photo/Richard Drew, File)
January 25, 2019 - 4:42 pm
NEW YORK (AP) — Stocks closed higher on Wall Street Friday, recovering a chunk of their losses from earlier in the week. Technology and industrial companies jumped. Traders took a brighter view on the economy, and U.S. companies continued to report solid results for the fourth quarter. Energy and...
Read More

Pages